<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-28905" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Septic Bursitis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Truong</surname>
            <given-names>Justina</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mabrouk</surname>
            <given-names>Ahmed</given-names>
          </name>
          <aff>National Health Service (NHS), United Kingdom</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ashurst</surname>
            <given-names>John V.</given-names>
          </name>
          <aff>Kingman Regional Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Justina Truong declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ahmed Mabrouk declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>John Ashurst declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>22</day>
          <month>4</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-28905.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Bursae are fluid-filled sacs that produce small amounts of synovial fluid to reduce friction between mobile structures of the musculoskeletal system. Inflammation of the bursa due to prolonged pressure, overuse, trauma or arthritis, causes excess fluid production and leads to swelling and irritation, known as bursitis. Septic (or infectious) bursitis occurs when infection from either direct inoculation, hematogenous or direct spread from other sites causes inflammatory bursitis. Bursa aspiration and fluid analysis must be completed to make an accurate diagnosis. This activity reviews the evaluation and management of septic bursitis and highlights the role of the interprofessional team to improve care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review the causes of septic bursitis.</p></list-item><list-item><p>Describe the work up of a patient with septic bursitis.</p></list-item><list-item><p>Summarize the treatment options for septic bursitis.</p></list-item><list-item><p>Outline the importance of improving care coordination among the interprofessional team members to detect the condition using bursa aspiration and fluid analysis to enhance the delivery of care in patients with septic bursitis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28905&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28905">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-28905.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Bursae&#x000a0;are fluid-filled sac-like structures located between mobile structures of the musculoskeletal system, between skin and bone, or between the joints. There are upward of 150 superficial and deep bursae&#x000a0;located in between bone, muscle, tendons, and skin. Small amounts of synovial fluid are produced within the bursa and&#x000a0;reduce friction by lubrication. Inflammation of the bursa causes excess fluid production and leads to swelling and irritation, known as bursitis. This inflammation can be caused by prolonged pressure, overuse, inflammatory and crystalloid arthritis, and direct injury or trauma. Common locations of bursitis include prepatellar, olecranon, and trochanteric.<xref ref-type="bibr" rid="article-28905.r1">[1]</xref><xref ref-type="bibr" rid="article-28905.r2">[2]</xref><xref ref-type="bibr" rid="article-28905.r3">[3]</xref><xref ref-type="bibr" rid="article-28905.r4">[4]</xref></p>
        <p>Septic (or infectious) bursitis occurs when&#x000a0;infection from either direct inoculation (usually superficial bursa) or hematogenous or direct spread from other sites (deep bursa involvement) causes inflammatory bursitis. Septic bursitis can be acute, subacute, or recurrent/chronic. The clinical features of septic bursitis are sometimes indistinguishable from non-infectious bursitis; therefore, bursa aspiration and fluid analysis must be completed to make an accurate diagnosis.</p>
      </sec>
      <sec id="article-28905.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Inoculating the bursa with infections bacteria causes septic bursitis. This happens most often from micro-trauma or direct puncture of the overlying skin causing subsequent infection. Contiguous spread of overlying cellulitis of the skin is also a common cause of superficial septic bursitis. In 80% to 90% of cases, <italic toggle="yes">Staphylococcus aureus</italic> is the most common organism in acute septic bursitis and <italic toggle="yes">Streptococcus</italic> species being the next. Other organisms include <italic toggle="yes">Escherichia coli</italic>, <italic toggle="yes">Enterococcus</italic>, <italic toggle="yes">Pseudomonas aeruginosa</italic>, and coagulase-negative staphylococci. Chronic, infectious bursitis is likely due to atypical mycobacteria and fungi and should warrant prompt evaluation for systemic infection.<xref ref-type="bibr" rid="article-28905.r5">[5]</xref><xref ref-type="bibr" rid="article-28905.r6">[6]</xref><xref ref-type="bibr" rid="article-28905.r7">[7]</xref></p>
      </sec>
      <sec id="article-28905.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Septic bursitis happens more commonly in males with the mean age at onset approximately 50 years. Some studies suggest increases in the incidence of septic bursitis in relation to people&#x000a0;with comorbid disease conditions, but most cases are due to repetitive trauma related to occupational behaviors. Plumbers, carpenters, roofers, clergy, and athletes are commonly affected. Septic bursitis can also be caused by joint steroid injections meant to relieve the symptoms of non-infectious bursitis. Patients with underlying crystal-induced arthropathy like Gout have an increased amount of bursal fluid and can have higher incidences of septic bursitis. People with inflammatory arthritis, for example, rheumatoid arthritis, are also at an increased risk.</p>
      </sec>
      <sec id="article-28905.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Bursitis is the result of inflammation that leads to increased fluid production from the synovial cells that line the bursa. Increased fluid production leads to increasing pressure of the bursa and in the result, increased pain. Trauma or puncture of skin at the site of a bursa can lead to the direct introduction of bacteria and subsequent inflammation and infection. Overlying skin and soft tissue infections such as cellulitis can also lead to secondary infectious bursitis. In deep bursa, an&#x000a0;infectious spread is more likely related to spread from blood or joint infections such as septic arthritis.</p>
      </sec>
      <sec id="article-28905.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>History may allude to the recent trauma of the affected area or an occupation suspicious for a high likelihood of septic bursitis. Therefore, it is important to ask relevant questions. Clinical findings may be indistinguishable from non-infectious bursitis and sometimes even a septic joint. Patients with septic bursitis are more likely to present with pain or tenderness overlying the bursa, edema, erythema, and warmth. Patients may also have signs of trauma or wounds and lesions with or without symptoms of cellulitis. Fever may or may not be present but is more likely to be present when bursitis is infectious versus when it is non-infectious. Joint motion is usually unaffected in septic bursitis and likely limited with septic arthritis. The findings discussed above are not completely reliable in distinguishing between infectious and non-infectious bursitis, and therefore, additional diagnostic testing must be done. In a nutshell, the following should be the focus of the examination; swelling size, consistency (soft, firm, hard), fluctuance, associated&#x000a0;cellulitis, and&#x000a0;any lymphadenopathy. Also, the range of movement and pain of the adjacent joint should be carefully assessed and documented.</p>
      </sec>
      <sec id="article-28905.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Ideally, investigations checking inflammatory markers and blood culture should be performed prior to starting antibiotic therapy.&#x000a0;Routine blood work is somewhat unhelpful in the diagnosis and distinguishing septic bursitis versus non-infectious bursitis. The peripheral white blood count (WBC) may not differ between infectious and non-infectious bursitis and may not even be elevated above the normal range. However, C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) usually&#x000a0;are elevated in septic bursitis. A uric blood acid level should also be checked if suspicion of underlying crystal arthropathy exists. Antinuclear antibody and rheumatoid factor can be ordered in chronic cases or when the underlying autoimmune disease is suspected. Plain film radiography is usually performed, but it is unnecessary and unhelpful in most cases of septic bursitis. Spurs may be seen in chronic cases of bursitis, but joint effusions are not normally present. Computed tomography (CT) and magnetic resonance imagining (MRI)&#x000a0;are not needed unless suspicion for osteomyelitis or septic arthritis exists, or if the physician is evaluating a severe case&#x000a0;of septic bursitis in which surgical management may be necessary.<xref ref-type="bibr" rid="article-28905.r8">[8]</xref><xref ref-type="bibr" rid="article-28905.r9">[9]</xref><xref ref-type="bibr" rid="article-28905.r10">[10]</xref>.Magnetic resonance imaging has been reported in the literature as a reliable negative predictor of septic bursitis when there is no bursal and soft tissue enhancement&#x000a0;<xref ref-type="bibr" rid="article-28905.r11">[11]</xref>.</p>
        <p>&#x000a0;Aspiration and analysis of bursal fluid is the gold standard of diagnostic criteria. A bursal fluid analysis should always be performed in any case of bursitis to rule out septic or crystal-induced bursitis. Fluid should be evaluated for cell count with differential, gram stain, culture, and crystals.&#x000a0;In recent literature summaries, the average bursal WBC was found to be around 63,000/mm; although, other studies show leukocytosis of more than 2000/mm was 94% sensitive and 79% specific for septic bursitis. Septic bursitis usually has a predominance of polymorphonuclear leukocytes while non-infectious has a predominance of mononuclear cells. Gram staining can vary between 15% and 100% sensitive and may only be positive in half of septic bursitis cases. However, a&#x000a0;negative gram stain with WBC more than 50,000/hpf, and clinical signs and suspicion for septic bursitis should be treated accordingly. The culture of bursal fluid should always be done in order to evaluate for any bacterial growth in order to help guide treatment.</p>
      </sec>
      <sec id="article-28905.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Although non-infectious bursitis can be managed with conservative measures aimed at reducing inflammation, treatment for septic bursitis is always antibiotic therapy. Injection of non-steroidal anti-inflammatory drugs (NSAIDs) can be offered to control pain and injection of corticosteroids can be offered to cases where pain can not be controlled by NSAIDs. Treatment can be done on&#x000a0;an outpatient basis with or without needle aspiration&#x000a0;<xref ref-type="bibr" rid="article-28905.r12">[12]</xref><xref ref-type="bibr" rid="article-28905.r13">[13]</xref>; although, inpatient treatment with intravenous antibiotic therapy may be needed in patients who are immunocompromised, show systemic signs and symptoms, or have joint involvement&#x000a0;<xref ref-type="bibr" rid="article-28905.r14">[14]</xref>.&#x000a0;Antibiotic therapy should initially be aimed at the most likely organisms and tailored as needed to gram-stain and culture results. Methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic> coverage with oral clindamycin, doxycycline,&#x000a0;or trimethoprim-sulfamethoxazole is recommended for empiric therapy until culture results are finalized. If there is a severe local infection or in an immunocompromised patient, admission for intravenous vancomycin is most appropriate. For those patients with a penicillin allergy, the recommended treatment is ciprofloxacin and rifampin.&#x000a0;</p>
        <p>Duration and type of therapy are debated.&#x000a0;Recommendations include a minimum of 10 days of treatment in mild cases, and repeat aspirations and continuation of antibiotics until bursal fluid is clear of infectious signs in severe cases. Treatment can usually be guided by clinical response and culture results</p>
        <p>
<bold>Indications for Operative Intervention</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Significant pointing swellings <xref ref-type="bibr" rid="article-28905.r15">[15]</xref>.</p>
          </list-item>
          <list-item>
            <p>Severe cases that are unresponsive to medical treatment with antibiotics alone.</p>
          </list-item>
          <list-item>
            <p>Chronic cases.</p>
          </list-item>
          <list-item>
            <p>Recurrent cases.</p>
          </list-item>
        </list>
        <p>
<bold>Operative Intervention</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Needle aspiration together with systemic antibiotics.</p>
          </list-item>
          <list-item>
            <p>Incision and drainage if aspiration fails due to loculation <xref ref-type="bibr" rid="article-28905.r15">[15]</xref>.</p>
          </list-item>
          <list-item>
            <p>Suction irrigation&#x000a0;<xref ref-type="bibr" rid="article-28905.r16">[16]</xref>.</p>
          </list-item>
          <list-item>
            <p>Open or arthroscopic bursectomy: it was reported that single-stage acute bursectomy has higher recurrence rates&#x000a0;in comparison to&#x000a0;two-stage&#x000a0;bursectomy&#x000a0;with delayed primary closure&#x000a0;<xref ref-type="bibr" rid="article-28905.r14">[14]</xref>. The arthroscopic approach has a lower risk of wound complications in comparison with open approach.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28905.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Cellulitis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Gout and Pseudogout</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Rheumatoid Arthritis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Soft Tissue Knee Injury</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Tendonitis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28905.s10" sec-type="Staging">
        <title>Staging</title>
        <p><bold>Ho and Su classification system</bold> based on clinical signs&#x000a0;<xref ref-type="bibr" rid="article-28905.r12">[12]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Mild Bursitis: local inflammation with no associated systemic signs.</p>
          </list-item>
          <list-item>
            <p>Moderate Bursitis: significant local inflammation with or without mild systemic signs.</p>
          </list-item>
          <list-item>
            <p>Severe Bursitis: intense peri-bursal cellulitis with or without infected wound with systemic signs e.g.&#x000a0;pyrexia or rigors, or a serum leukocytosis &#x0003e;10,000/mm.</p>
          </list-item>
        </list>
        <p>Severity within the classification increases one level if there is a comorbidity that is likely to affect healing or immune response.</p>
      </sec>
      <sec id="article-28905.s11" sec-type="Complications">
        <title>Complications</title>
        <list list-type="bullet">
          <list-item>
            <p>Bursa rupture.</p>
          </list-item>
          <list-item>
            <p>Osteomyelitis.</p>
          </list-item>
          <list-item>
            <p>Wound healing problems (e.g. Dehiscence, excessive exudate, chronic sinus and skin necrosis).</p>
          </list-item>
          <list-item>
            <p>Recurrence: The most significant independent risk factor for recurrence is failure to intervene operatively when it is indicated (14.6% versus 80%) <xref ref-type="bibr" rid="article-28905.r14">[14]</xref>. Whilst, in post operative cases, immunosuppression is the single independent risk factor for recurrence.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28905.s12" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Although debate over the duration of treatment exists, the fact of the matter is septic bursitis requires antibiotic treatment. Chronic septic bursitis can develop if&#x000a0;initially&#x000a0;not treated appropriately. Complications such as osteomyelitis and continual pain can occur. Overlying ligaments and tendons can become weak and may rupture due to chronic infection. Therefore, tendinitis must be a consideration when diagnosing septic bursitis.</p>
      </sec>
      <sec id="article-28905.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The management of septic bursitis requires an interprofessional effort. The majority of patients are first seen by the emergency department, primary provider or nurse practitioner. Once the condition has been diagnosed, some patients may be referred to the orthopedic&#x000a0;surgeon for more definitive&#x000a0;treatment. Most patients are managed as outpatients but the duration of therapy remains unknown. Because there is a potential of developing osteomyelitis, these patients must be closely monitored. Duration and type of therapy are debated.&#x000a0;Recommendations include a minimum of 10 days of treatment in mild cases, and repeat aspirations and continuation of antibiotics until bursal fluid is clear of infectious signs in severe cases. Treatment can usually be guided by clinical response and culture results. The outcomes in most patients with septic bursitis are good.&#x000a0;<xref ref-type="bibr" rid="article-28905.r7">[7]</xref><xref ref-type="bibr" rid="article-28905.r17">[17]</xref></p>
      </sec>
      <sec id="article-28905.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28905&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28905">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/joint-muscle-and-bone/septic-bursitis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=28905">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/28905/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=28905">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-28905.s15">
        <title>References</title>
        <ref id="article-28905.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Glass</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Everist</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Spencer</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Methicillin-resistant <italic>Staphylococcal aureus</italic> patellar tendon abscess and septic prepatellar bursitis in an injection drug user.</article-title>
            <source>Radiol Case Rep</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>238</fpage>
            <page-range>238-241</page-range>
            <pub-id pub-id-type="pmid">30479679</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28905.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DeRogatis</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Parameswaran</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mayer</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Issack</surname>
                <given-names>PS</given-names>
              </name>
            </person-group>
            <article-title>Septic Shoulder Joint After Pneumococcal Vaccination Requiring Surgical Debridement.</article-title>
            <source>HSS J</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>14</volume>
            <issue>3</issue>
            <fpage>299</fpage>
            <page-range>299-301</page-range>
            <pub-id pub-id-type="pmid">30258336</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28905.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Herring</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mathern</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Khodaee</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Septic Infrapatellar Bursitis in an Immunocompromised Female.</article-title>
            <source>Case Rep Orthop</source>
            <year>2018</year>
            <volume>2018</volume>
            <fpage>9086201</fpage>
            <pub-id pub-id-type="pmid">29984025</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28905.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Parker</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Leggit</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Novel Treatment of Prepatellar Bursitis.</article-title>
            <source>Mil Med</source>
            <year>2018</year>
            <month>Nov</month>
            <day>01</day>
            <volume>183</volume>
            <issue>11-12</issue>
            <fpage>e768</fpage>
            <page-range>e768-e770</page-range>
            <pub-id pub-id-type="pmid">29800302</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28905.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blumberg</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Long</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Koyfman</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Clinical Mimics: An Emergency Medicine-Focused Review of Cellulitis Mimics.</article-title>
            <source>J Emerg Med</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>53</volume>
            <issue>4</issue>
            <fpage>475</fpage>
            <page-range>475-484</page-range>
            <pub-id pub-id-type="pmid">29079067</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28905.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oda</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sekikawa</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hongo</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Meningococcal Bursitis.</article-title>
            <source>Intern Med</source>
            <year>2017</year>
            <month>Dec</month>
            <day>15</day>
            <volume>56</volume>
            <issue>24</issue>
            <fpage>3403</fpage>
            <page-range>3403-3404</page-range>
            <pub-id pub-id-type="pmid">29021440</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28905.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lieber</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Fowler</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shmerling</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Paz</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Clinical characteristics and outcomes of septic bursitis.</article-title>
            <source>Infection</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>45</volume>
            <issue>6</issue>
            <fpage>781</fpage>
            <page-range>781-786</page-range>
            <pub-id pub-id-type="pmid">28555416</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28905.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hanrahan</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Recent developments in septic bursitis.</article-title>
            <source>Curr Infect Dis Rep</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>15</volume>
            <issue>5</issue>
            <fpage>421</fpage>
            <page-range>421-5</page-range>
            <pub-id pub-id-type="pmid">23933823</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28905.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reed</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Carachi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Management of the nontraumatic hot swollen joint.</article-title>
            <source>Eur J Emerg Med</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>19</volume>
            <issue>2</issue>
            <fpage>103</fpage>
            <page-range>103-7</page-range>
            <pub-id pub-id-type="pmid">21730866</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28905.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wasserman</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Melville</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Birkhahn</surname>
                <given-names>RH</given-names>
              </name>
            </person-group>
            <article-title>Septic bursitis: a case report and primer for the emergency clinician.</article-title>
            <source>J Emerg Med</source>
            <year>2009</year>
            <month>Oct</month>
            <volume>37</volume>
            <issue>3</issue>
            <fpage>269</fpage>
            <page-range>269-72</page-range>
            <pub-id pub-id-type="pmid">17976775</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28905.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Floemer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Morrison</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Bongartz</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ledermann</surname>
                <given-names>HP</given-names>
              </name>
            </person-group>
            <article-title>MRI characteristics of olecranon bursitis.</article-title>
            <source>AJR Am J Roentgenol</source>
            <year>2004</year>
            <month>Jul</month>
            <volume>183</volume>
            <issue>1</issue>
            <fpage>29</fpage>
            <page-range>29-34</page-range>
            <pub-id pub-id-type="pmid">15208103</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28905.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ho</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>EY</given-names>
              </name>
            </person-group>
            <article-title>Antibiotic therapy of septic bursitis. Its implication in the treatment of septic arthritis.</article-title>
            <source>Arthritis Rheum</source>
            <year>1981</year>
            <month>Jul</month>
            <volume>24</volume>
            <issue>7</issue>
            <fpage>905</fpage>
            <page-range>905-11</page-range>
            <pub-id pub-id-type="pmid">7259803</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28905.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Laupland</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>HD</given-names>
              </name>
              <collab>Calgary Home Parenteral Therapy Program Study Group</collab>
            </person-group>
            <article-title>Olecranon septic bursitis managed in an ambulatory setting. The Calgary Home Parenteral Therapy Program Study Group.</article-title>
            <source>Clin Invest Med</source>
            <year>2001</year>
            <month>Aug</month>
            <volume>24</volume>
            <issue>4</issue>
            <fpage>171</fpage>
            <page-range>171-8</page-range>
            <pub-id pub-id-type="pmid">11558851</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28905.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Perez</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Huttner</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Assal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bernard</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lew</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hoffmeyer</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>U&#x000e7;kay</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Infectious olecranon and patellar bursitis: short-course adjuvant antibiotic therapy is not a risk factor for recurrence in adult hospitalized patients.</article-title>
            <source>J Antimicrob Chemother</source>
            <year>2010</year>
            <month>May</month>
            <volume>65</volume>
            <issue>5</issue>
            <fpage>1008</fpage>
            <page-range>1008-14</page-range>
            <pub-id pub-id-type="pmid">20197288</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28905.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raddatz</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Hoffman</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Franck</surname>
                <given-names>WA</given-names>
              </name>
            </person-group>
            <article-title>Septic bursitis: presentation, treatment and prognosis.</article-title>
            <source>J Rheumatol</source>
            <year>1987</year>
            <month>Dec</month>
            <volume>14</volume>
            <issue>6</issue>
            <fpage>1160</fpage>
            <page-range>1160-3</page-range>
            <pub-id pub-id-type="pmid">3437425</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28905.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Knight</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Maurer</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>Treatment of septic olecranon and prepatellar bursitis with percutaneous placement of a suction-irrigation system. A report of 12 cases.</article-title>
            <source>Clin Orthop Relat Res</source>
            <year>1986</year>
            <month>May</month>
            <issue>206</issue>
            <fpage>90</fpage>
            <page-range>90-3</page-range>
            <pub-id pub-id-type="pmid">3011340</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28905.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sayegh</surname>
                <given-names>ET</given-names>
              </name>
              <name>
                <surname>Strauch</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Treatment of olecranon bursitis: a systematic review.</article-title>
            <source>Arch Orthop Trauma Surg</source>
            <year>2014</year>
            <month>Nov</month>
            <volume>134</volume>
            <issue>11</issue>
            <fpage>1517</fpage>
            <page-range>1517-36</page-range>
            <pub-id pub-id-type="pmid">25234151</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
